Bryan Smith, associate professor of biomedical engineering at MSU, and a team of scientists created a “Trojan Horse” nanoparticle that can be directed to eat debris, reducing and stabilizing plaque. The discovery could be a potential treatment for atherosclerosis, a leading cause of death in the United States.
The results, published in the current issue of Nature Nanotechnology, showcases the nanoparticle that homes in on atherosclerotic plaque due to its high selectivity to a particular immune cell type – monocytes and macrophages. Once inside the macrophages in those plaques, it delivers a drug agent that stimulates the cell to engulf and eat cellular debris. Basically, it removes the diseased/dead cells in the plaque core. By reinvigorating the macrophages, plaque size is reduced and stabilized.
Smith said that future clinical trials on the nanoparticle are expected to reduce the risk of most types of heart attacks, with minimal side effects due to the unprecedented selectivity of the nanodrug.
Smith’s studies focus on intercepting the signaling of the receptors in the macrophages and sending a message via small molecules using nano-immunotherapeutic platforms. Previous studies have acted on the surface of the cells, but this new approach works intracellularly and has been effective in stimulating macrophages.
“We found we could stimulate the macrophages to selectively eat dead and dying cells – these inflammatory cells are precursor cells to atherosclerosis – that are part of the cause of heart attacks,” Smith said. “We could deliver a small molecule inside the macrophages to tell them to begin eating again.”
This approach also has applications beyond atherosclerosis, he added.
“We were able to marry a groundbreaking finding in atherosclerosis by our collaborators with the state-of-the-art selectivity and delivery capabilities of our advanced nanomaterial platform. We demonstrated the nanomaterials were able to selectively seek out and deliver a message to the very cells needed,” Smith said. “It gives a particular energy to our future work, which will include clinical translation of these nanomaterials using large animal models and human tissue tests. We believe it is better than previous methods.”
Smith has filed a provisional patent and will begin marketing it later this year.
A link to the original paper: https://www.nature.com/articles/s41565-019-0619-3
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Trojan Horse nanoparticle
- Nonviral Vectors for the Delivery of Small Interfering RNAs to the CNSon November 24, 2020 at 4:00 pm
They are not effective for gene delivery to the brain when administered intravenously, although 'Trojan horse' liposomes can be an exception. These nanoparticles have a better transfection ...
- Dietary Supplements and Minerals Newson November 23, 2020 at 4:00 pm
Sep. 23, 2020 — Cancer cells are killed in lab experiments and tumor growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to ...
- Nanobiotechnology-Based Strategies for Crossing the Blood–Brain Barrieron November 21, 2020 at 4:00 pm
Several nanoparticles (NPs ... NPs for enhancing monoclonal antibody delivery across the BBB by the Trojan horse approach, use of peptide–NP conjugates and two commercial technologies ...
- Volunteers still needed to test variety of COVID-19 vaccineson November 17, 2020 at 3:02 pm
Trojan horse vaccines A different way to target ... spike protein in the laboratory and packaging them into virus-sized nanoparticles. Malik Reed is developing into Broncos’ most effective ...
- Volunteers still needed to test variety of COVID-19 vaccineson November 17, 2020 at 8:58 am
Two COVID-19 vaccines might be nearing the finish line, but scientists say it's critical that enough people volunteer to help finish studying other candidates ...
Go deeper with Google Headlines on:
Trojan Horse nanoparticle
Go deeper with Bing News on:
- Protein regulating inflammation in atherosclerosis identifiedon November 27, 2020 at 9:16 am
The protein CARD8 regulates several inflammatory proteins in people with atherosclerosis. This is shown in a new study by Örebro researchers published in the scientific journal Scientific Reports.
- CARD8 protein regulates inflammatory process in atherosclerosis, study showson November 26, 2020 at 3:22 pm
The protein CARD8 regulates several inflammatory proteins in people with atherosclerosis. This is shown in a new study by örebro researchers published in the scientific journal Scientific Reports.
- Association Between Clogged Arteries and Body Size Phenotype? Study Finds, “It Varies”on November 25, 2020 at 8:43 am
A recent study, published in The Journal of Clinical Endocrinology and Metabolism, sought to dive further into the impact of body size phenotypes on cardiovascular risk and effectively evaluate the ...
- White Supremacist Leader Tom Metzger Was Cremated, Riverside County Sayson November 24, 2020 at 2:41 pm
According to a death certificate for the notorious former KKK leader, he also suffered from atherosclerosis and anemia, which contributed to his passing in Hemet. The certificate — listing the d ...
- Pre-treating progenitor cells with protein-activator slows progression of atherosclerosison November 24, 2020 at 6:02 am
Durham, NC - A new treatment for atherosclerosis, commonly known as hardening of the arteries, may be on the horizon, according to a study released today in STEM CELLS Translational Medicine (SCTM).